Basel Medical Group Cash Flow Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Net Income	0.43	2.07	1.78	1.98
Depreciation & Amortization	0.62	0.53	0.56	0.58
Asset Writedown & Restructuring Costs	-	-	0.05	-
Provision & Write-off of Bad Debts	-0.01	-0.01	0.16	0.03
Other Operating Activities	-0.5	-0.08	-0.23	0.13
Change in Accounts Receivable	-1.86	-0.42	0.54	0.01
Change in Inventory	0.01	0.02	-0.02	0
Change in Accounts Payable	-0.11	0.39	-0.22	0.06
Operating Cash Flow	-1.42	2.51	2.6	2.79
Operating Cash Flow Growth	-	-3.49%	-6.89%	-
Capital Expenditures	-0.02	-0.01	-0.01	-0.09
Investing Cash Flow	0.04	-0.01	-0.01	-0.09
Short-Term Debt Issued	-	1.42	-	-
Long-Term Debt Issued	-	-	-	1.03
Total Debt Issued	5.39	1.42	-	1.03
Short-Term Debt Repaid	-	-	-	-10.86
Long-Term Debt Repaid	-	-2.92	-2.94	-3.09
Total Debt Repaid	-6.78	-2.92	-2.94	-13.95
Net Debt Issued (Repaid)	-1.39	-1.5	-2.94	-12.92
Other Financing Activities	9.3	-0.27	0	-
Financing Cash Flow	7.9	-1.77	-2.94	-12.92
Net Cash Flow	6.5	0.73	-0.35	-10.22
Free Cash Flow	-1.44	2.5	2.59	2.7
Free Cash Flow Growth	-	-3.56%	-4.07%	-
Free Cash Flow Margin	-14.40%	24.84%	26.61%	25.37%
Free Cash Flow Per Share	-0.09	0.15	0.16	0.17
Cash Interest Paid	0.18	0.18	0.24	0.32
Cash Income Tax Paid	0.33	0.41	0.29	0.03
Levered Free Cash Flow	11.22	1.43	1.89	-
Unlevered Free Cash Flow	11.4	1.54	2.04	-
Change in Working Capital	-1.96	-0	0.29	0.08

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q